ORBIMED ADVISORS LLC – Aerovate Therapeutics, Inc. Transaction History
ORBIMED ADVISORS LLC portfolio value:
$13.18M
portfolio value
ORBIMED ADVISORS LLC quarter portfolio value change:
+6.08%
quarter
Aerovate Therapeutics, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +66.12% | 316.42K shares | 5.70M | $16.58 | 795K |
| Q2 2022 | share | Decrease | -6.15% | -31.37K shares | -1.86M | $15.63 | 478.57K |
| Q1 2022 | share | Decrease | -4.81% | -25.76K shares | 3.03M | $18.33 | 509.94K |
| Q4 2021 | share | 0.00% | 0 shares | -4.92M | $11.19 | 535.71K | |
| Q3 2021 | share | 0.00% | 0 shares | -991K | $20.98 | 535.71K | |
| Q2 2021 | share | Increase | 0.00% | 535.71K shares | 12.23M | $22.83 | 535.71K |